Covid-19: Potential new ‘vaccine tablet’ produces antibodies with one dose

Covid-19: Potential new ‘vaccine tablet’ produces antibodies with one dose

An oral vaccine developed by an Indian pharmaceutical firm and an Israeli-American company has been found to produce Covid-19 antibodies in animals after only one dose.

The ‘Oravax' capsule combines the Premas Biotech vaccine with Oramed technology, which makes it possible to orally ingest a medication that would normally be delivered by injection.

The clinical data from the animal study is yet to be shared, but the development of an oral vaccine raises the possibility of people being able to self-vaccinate.





We are very excited about our oral vaccine candidate's potential to help end the pandemic

Nadav